DGAP-Adhoc: MOLOGEN AG carries out a capital increase from authorized capital


MOLOGEN AG  / Key word(s): Capital Increase

27.03.2012 19:34

Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted
by DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.

---------------------------------------------------------------------------

The Management Board of MOLOGEN AG decided today with the agreement of the
Supervisory Board to use the existing authorized capital 2011 in accordance
with Para. 4 section 3 of the Articles of Association and to carry out a
capital increase without subscription rights. By issuing up to 300,000 new
shares at a price of EUR 9.00 per share, the current share capital of EUR
12,459,275 is set to increase to up to EUR 12,759,275. The inflow of funds
from the capital increase serves to strengthen the equity capital basis and
in particular to expand the product pipeline and to finance the ongoing
business operations which are necessary for this. The new shares shall
carry dividend rights as of January 1, 2011.

After taking the decision the new shares have been subscribed to the full
extent through a private placement. Therewith MOLOGEN AG will receive gross
proceeds of EUR 2.7 million.


---------------------------------------------------------------------------

Information and Explaination of the Issuer to this News:

PRESS SERVICE:
Prof. Peter W. Huebner
Head of Corporate Communications
Tel:  +49 - 30 - 84 17 88 - 38
Tel:  +49 - 30 - 84 17 88 - 50
huebner@mologen.com

INVESTOR RELATIONS:
Joerg Petrass
Tel:  +49 - 30 - 84 17 88 - 13
Tel:  +49 - 30 - 84 17 88 - 50
investor@mologen.com

External Investor Relations:
Kirchhoff Consult AG
Sebastian Bucher
T:  +49 - 40 - 60 91 86 - 18
F:  +49 - 40 - 60 91 86 -16
sebastian.bucher@kirchhoff.de

Note about risk for future predictions
Certain information in this report contains forward-looking statements or
the corresponding statements with negation or versions deviating from this
or comparable terminology. These are described as forward-looking
statements. In addition, all of the information given here that refers to
planned or future results of business areas, key financial figures,
developments of the financial situation or other financial figures or
statistical data, is to be understood as such forward-looking statements.
The company points out to investors that they should not rely on these
forward-looking statements as predictions about actual future events. The
company is not obligated and refuses to accept any liability for the
forward-looking statements and has no obligation to update such statements
in order to accurately reflect the current situation.

27.03.2012 DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------------
 
Language:     English
Company:      MOLOGEN AG
              Fabeckstraße 30
              14195 Berlin
              Germany
Phone:        030 / 841788-0
Fax:          030 / 841788-50
E-mail:       info@mologen.com
Internet:     www.mologen.com
ISIN:         DE0006637200
WKN:          663720
Listed:       Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr
              in Berlin, Düsseldorf, Hamburg, München, Stuttgart
 
End of Announcement                             DGAP News-Service
 
---------------------------------------------------------------------------